Details of Drug

Drug General Information (ID: D0700)
Drug Name	Fostemsavir
Drug Type	Small molecule
Drug Synonymous	BMS-216; BMS-248; BMS-378806; BMS-626529; BMS-705; BMS-806; BMS-806 series; BMS-853; HIV-1 attachment inhibitors, BMS; HIV-1 entry inhibitors, BMS; BMS-488043 follow-on compounds, BMS; HIV-1 attachment inhibitors, Bristol-Myers Squibb Click to Show/Hide
Disease Class	1C60-1C62: Human immunodeficiency virus disease
Therapeutic Class	Antiviral Agents
Structure
Structure	3D Structure		2D Structure
Formula	C25H26N7O8P
InChI	1S/C25H26N7O8P/c1-16-27-14-32(28-16)23-21-20(19(39-2)12-26-23)18(13-31(21)15-40-41(36,37)38)22(33)25(35)30-10-8-29(9-11-30)24(34)17-6-4-3-5-7-17/h3-7,12-14H,8-11,15H2,1-2H3,(H2,36,37,38)
InChIKey	SWMDAPWAQQTBOG-UHFFFAOYSA-N
Canonical SMILES	CC1=NN(C=N1)C2=NC=C(C3=C2N(C=C3C(=O)C(=O)N4CCN(CC4)C(=O)C5=CC=CC=C5)COP(=O)(O)O)OC
External Link
	Pubchem ID	11319217
	CAS Number	864953-29-7
	TTD ID	D00ZCT

Drug-Drug Interaction Network
Sunburst Graph		Legend Information AM002 Affected cellular transport AM004 Affected intra/extra-hepatic metabolism AM006 Pharmacodynamic additive effects BM010 Transporter inhibition BM017 CYP450 enzyme inhibition BM022 CYP450 enzyme induction BM076 Increased risk of prolong QT interval BM081 Increased risk of ventricular arrhythmias
Relation Graph

Full list of drugs interacting with Fostemsavir
Affected cellular transport
	Transporter inhibition					Drug Num: 38
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0739		Grazoprevir	C38H50N6O9S	44603531	Major		Inter Info	[3], [64], [65]
D0026		Afatinib	C24H25ClFN5O3	10184653	Moderate		Inter Info	[50]
D0053		Ambrisentan	C22H22N2O4	6918493	Moderate		Inter Info	[50]
D0109		Artesunate	C19H28O8	6917864	Moderate		Inter Info	[50]
D0120		Atorvastatin	C33H35FN2O5	60823	Moderate		Inter Info	[50]
D0194		Bosentan	C27H29N5O6S	104865	Moderate		Inter Info	[50]
D0303		Cerivastatin	C26H34FNO5	446156	Moderate		Inter Info	[50]
D0348		Cladribine	C10H12ClN5O3	20279	Moderate		Inter Info	[50]
D0375		Cobicistat	C40H53N7O5S2	25151504	Moderate		Inter Info	[50]
D0565		Empagliflozin	C23H27ClO7	11949646	Moderate		Inter Info	[50]
D0631		Ezetimibe	C24H21F2NO3	150311	Moderate		Inter Info	[50]
D0656		Fexofenadine	C32H39NO4	3348	Moderate		Inter Info	[50]
D0686		Fluvastatin	C24H26FNO4	446155	Moderate		Inter Info	[50]
D0044		Alpelisib	C19H22F3N5O2S	56649450	Moderate		Inter Info	[50]
D0438		Delafloxacin	C18H12ClF3N4O4	487101	Moderate		Inter Info	[50]
D0963		Lusutrombopag	C29H32Cl2N2O5S	49843517	Moderate		Inter Info	[13]
D1396		Revefenacin	C35H43N5O4	11753673	Moderate		Inter Info	[206], [64], [207]
D1407		Rimegepant	C28H28F2N6O3	51049968	Moderate		Inter Info	[208]
D0730		Glyburide	C23H28ClN3O5S	3488	Moderate		Inter Info	[50]
D0793		Imatinib	C29H31N7O	5291	Moderate		Inter Info	[50]
D0845		Irinotecan	C33H38N4O6	60838	Moderate		Inter Info	[50]
D0867		Itraconazole	C35H38Cl2N8O4	55283	Moderate		Inter Info	[50]
D0956		Lovastatin	C24H36O5	53232	Moderate		Inter Info	[50]
D1025		Methotrexate	C20H22N8O5	126941	Moderate		Inter Info	[50]
D1079		Mitoxantrone	C22H28N4O6	4212	Moderate		Inter Info	[50]
D1170		Olmesartan	C24H26N6O3	158781	Moderate		Inter Info	[50]
D1301		Pitavastatin	C25H24FNO4	5282452	Moderate		Inter Info	[50]
D1329		Pravastatin	C23H36O7	54687	Moderate		Inter Info	[50]
D1392		Repaglinide	C27H36N2O4	65981	Moderate		Inter Info	[50]
D1415		Ritonavir	C37H48N6O5S2	392622	Moderate		Inter Info	[50]
D1417		Rivaroxaban	C19H18ClN3O5S	9875401	Moderate		Inter Info	[50]
D1430		Rosuvastatin	C22H28FN3O6S	446157	Moderate		Inter Info	[50]
D1457		Selexipag	C26H32N4O4S	9913767	Moderate		Inter Info	[50]
D1471		Simeprevir	C38H47N5O7S2	24873435	Moderate		Inter Info	[50]
D1473		Simvastatin	C25H38O5	54454	Moderate		Inter Info	[50]
D1517		Sulfasalazine	C18H14N4O5S	5339	Moderate		Inter Info	[50]
D1556		Teriflunomide	C12H9F3N2O2	54684141	Moderate		Inter Info	[50]
D1610		Topotecan	C23H23N3O5	60700	Moderate		Inter Info	[50]
Affected intra/extra-hepatic metabolism
	CYP450 enzyme inhibition					Drug Num: 13
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0116		Atazanavir	C38H52N6O7	148192	Moderate		Inter Info	[50]
D0192		Boceprevir	C27H45N5O5	10324367	Moderate		Inter Info	[50]
D0426		Darunavir	C27H37N3O7S	213039	Moderate		Inter Info	[50]
D0439		Delavirdine	C22H28N6O3S	5625	Moderate		Inter Info	[50]
D0497		Diltiazem	C22H26N2O4S	39186	Moderate		Inter Info	[50]
D0692		Fosamprenavir	C25H36N3O9PS	131536	Moderate		Inter Info	[50]
D1653		Troleandomycin	C41H67NO15	202225	Moderate		Inter Info	[50]
D0789		Idelalisib	C22H18FN7O	11625818	Moderate		Inter Info	[50]
D0799		Indinavir	C36H47N5O4	5362440	Moderate		Inter Info	[50]
D1117		Nefazodone	C25H32ClN5O2	4449	Moderate		Inter Info	[50]
D1119		Nelfinavir	C32H45N3O4S	64143	Moderate		Inter Info	[50]
D1501		Spironolactone	C24H32O4S	5833	Moderate		Inter Info	[50]
D1541		Telaprevir	C36H53N7O6	3010818	Moderate		Inter Info	[50]
	CYP450 enzyme induction					Drug Num: 45
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0578		Enzalutamide	C21H16F4N4O2S	15951529	Major		Inter Info	[50]
D0697		Fosphenytoin	C16H15N2O6P	56339	Major		Inter Info	[50]
D0958		Lumacaftor	C24H18F2N2O5	16678941	Major		Inter Info	[80], [50]
D1078		Mitotane	C14H10Cl4	4211	Major		Inter Info	[50]
D1265		Phenobarbital	C12H12N2O3	4763	Major		Inter Info	[50]
D1401		Rifapentine	C47H64N4O12	135403821	Major		Inter Info	[50]
D1502		St. John's Wort	NA	NA	Major		Inter Info	[50]
D0061		Aminoglutethimide	C13H16N2O2	2145	Minor		Inter Info	[234], [50], [235]
D0071		Amobarbital	C11H18N2O3	2164	Minor		Inter Info	[234], [50], [235]
D0106		Armodafinil	C15H15NO2S	9690109	Minor		Inter Info	[50]
D0178		Bexarotene	C24H28O2	82146	Minor		Inter Info	[50]
D0224		Butabarbital	C10H16N2O3	2479	Minor		Inter Info	[50]
D0225		Butalbital	C11H16N2O3	2481	Minor		Inter Info	[234], [50], [235]
D0300		Cenobamate	C10H10ClN5O2	11962412	Minor		Inter Info	[50]
D0406		Dabrafenib	C23H20F3N5O2S2	44462760	Minor		Inter Info	[50]
D0432		Deferasirox	C21H15N3O4	214348	Minor		Inter Info	[50]
D0628		Etravirine	C20H15BrN6O	193962	Minor		Inter Info	[50]
D0639		Felbamate	C11H14N2O4	3331	Minor		Inter Info	[50]
D0204		Brigatinib	C29H39ClN7O2P	68165256	Minor		Inter Info	[50]
D0518		Doravirine	C17H11ClF3N5O3	58460047	Minor		Inter Info	[50]
D0555		Elagolix	C32H30F5N3O5	11250647	Minor		Inter Info	[234], [50], [235]
D0601		Eslicarbazepine	C15H14N2O2	9881504	Minor		Inter Info	[50]
D0901		Lemborexant	C22H20F2N4O2	56944144	Minor		Inter Info	[234], [50], [235]
D0953		Lorlatinib	C21H19FN6O2	71731823	Minor		Inter Info	[50]
D1258		Pexidartinib	C20H15ClF3N5	25151352	Minor		Inter Info	[234], [50], [235]
D1538		Tazemetostat	C34H44N4O4	66558664	Minor		Inter Info	[234], [50], [235]
D1546		Telotristat ethyl	C27H26ClF3N6O3	25181577	Minor		Inter Info	[234], [50], [235]
D0732		Glycerol phenylbutyrate	C33H38O6	10482134	Minor		Inter Info	[50]
D0741		Griseofulvin	C17H17ClO6	441140	Minor		Inter Info	[50]
D0905		Lesinurad	C17H14BrN3O2S	53465279	Minor		Inter Info	[234], [50], [235]
D1040		Methylphenobarbital	C13H14N2O3	8271	Minor		Inter Info	[234], [50], [235]
D1050		Metreleptin	NA	NA	Minor		Inter Info	[50]
D1081		Modafinil	C15H15NO2S	4236	Minor		Inter Info	[50]
D1099		Nafcillin	C21H22N2O5S	8982	Minor		Inter Info	[50]
D1128		Nevirapine	C15H14N4O	4463	Minor		Inter Info	[50]
D1186		Oritavancin	C86H97Cl3N10O26	16136912	Minor		Inter Info	[50]
D1198		Oxcarbazepine	C15H12N2O2	34312	Minor		Inter Info	[50]
D1248		Pentobarbital	C11H18N2O3	4737	Minor		Inter Info	[50]
D1274		Phenylbutazone	C19H20N2O2	4781	Minor		Inter Info	[234], [50], [235]
D1399		Rifabutin	C46H62N4O11	135398743	Minor		Inter Info	[50]
D1453		Secobarbital	C12H18N2O3	5193	Minor		Inter Info	[234], [50], [235]
D1494		Somatotropin	NA	NA	Minor		Inter Info	[234], [50], [235]
D1495		Somatrem	C43H72N14O14	5487805	Minor		Inter Info	[234], [50], [235]
D1518		Sulfinpyrazone	C23H20N2O3S	5342	Minor		Inter Info	[234], [50], [235]
D1652		Troglitazone	C24H27NO5S	5591	Minor		Inter Info	[234], [50], [235]
Pharmacodynamic additive effects
	Increased risk of prolong QT interval					Drug Num: 151
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0066		Amiodarone	C25H29I2NO3	2157	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0084		Anagrelide	C10H7Cl2N3O	135409400	Major		Inter Info	[1], [2], [3], [15]
D0149		Bedaquiline	C32H31BrN2O2	5388906	Major		Inter Info	[18]
D0170		Bepridil	C24H34N2O	2351	Major		Inter Info	[1], [7], [12]
D0230		Cabozantinib	C28H24FN3O5	25102847	Major		Inter Info	[3], [19]
D0302		Ceritinib	C28H36ClN5O3S	57379345	Major		Inter Info	[1], [2], [3], [20]
D0320		Chloroquine	C18H26ClN3	2719	Major		Inter Info	[21], [3], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39]
D0342		Cisapride	C23H29ClFN3O4	6917698	Major		Inter Info	[1], [2], [40]
D0345		Citalopram	C20H21FN2O	2771	Major		Inter Info	[1], [2], [3], [41], [42], [13], [43]
D0393		Crizotinib	C21H22Cl2FN5O	11626560	Major		Inter Info	[44]
D0508		Disopyramide	C21H29N3O	3114	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0513		Dofetilide	C19H27N3O5S2	71329	Major		Inter Info	[1], [2], [3], [45]
D0514		Dolasetron	C19H20N2O3	3033818	Major		Inter Info	[1], [2], [3], [46]
D0534		Dronedarone	C31H44N2O5S	208898	Major		Inter Info	[1], [2], [3], [47]
D0535		Droperidol	C22H22FN3O2	3168	Major		Inter Info	[1], [2], [3], [48], [49], [13]
D0599		Escitalopram	C20H21FN2O	146570	Major		Inter Info	[1], [51], [2], [3], [52], [53], [13]
D0872		Ivosidenib	C28H22ClF3N6O3	71657455	Major		Inter Info	[55], [56]
D0899		Lefamulin	C28H45NO5S	25185057	Major		Inter Info	[55], [57], [58]
D1459		Selpercatinib	C29H31N7O3	134436906	Major		Inter Info	[60], [58]
D0712		Gatifloxacin	C19H22FN3O4	5379	Major		Inter Info	[62], [1], [63]
D0740		Grepafloxacin	C19H22FN3O3	72474	Major		Inter Info	[2], [3], [66]
D0749		Halofantrine	C26H30Cl2F3NO	37393	Major		Inter Info	[2], [67], [68]
D0750		Haloperidol	C21H23ClFNO2	3559	Major		Inter Info	[1], [2], [3], [69], [70], [71], [72], [73], [74], [13]
D0779		Hydroxychloroquine	C18H26ClN3O	3652	Major		Inter Info	[21], [3], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39]
D0787		Ibutilide	C20H36N2O3S	60753	Major		Inter Info	[1], [2], [3], [75]
D0791		Iloperidone	C24H27FN2O4	71360	Major		Inter Info	[1], [2], [3], [76], [13]
D0909		Levacetylmethadol	C23H31NO2	15130	Major		Inter Info	[3], [79], [13]
D0960		Lumefantrine	C30H32Cl3NO	6437380	Major		Inter Info	[2], [3], [81]
D1010		Mesoridazine	C21H26N2OS2	4078	Major		Inter Info	[2], [3], [82]
D1017		Methadone	C21H27NO	4095	Major		Inter Info	[1], [2], [3], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [13]
D1063		Mifepristone	C29H35NO2	55245	Major		Inter Info	[1], [2], [3], [93]
D1092		Moxifloxacin	C21H24FN3O4	152946	Major		Inter Info	[62], [94], [95], [1], [2], [3], [96], [97], [98], [99], [100], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110], [111], [63], [112], [113], [114]
D1136		Nilotinib	C28H22F3N7O	644241	Major		Inter Info	[1], [2], [3], [115]
D1190		Osimertinib	C28H33N7O2	71496458	Major		Inter Info	[116]
D1221		Panobinostat	C21H23N3O2	6918837	Major		Inter Info	[117]
D1223		Papaverine	C20H21NO4	4680	Major		Inter Info	[118], [119], [120], [121], [122], [123], [124], [125]
D1230		Pasireotide	C58H66N10O9	9941444	Major		Inter Info	[1], [2], [3], [126]
D1292		Pimozide	C28H29F2N3O	16362	Major		Inter Info	[3], [48], [127], [13]
D1343		Procainamide	C13H21N3O	4913	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1371		Quinidine	C20H24N2O2	441074	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1398		Ribociclib	C23H30N8O	44631912	Major		Inter Info	[1], [2], [3], [48], [100], [128], [129], [13]
D1444		Saquinavir	C38H50N6O5	441243	Major		Inter Info	[130], [131], [1], [2], [3], [132], [133]
D1498		Sotalol	C12H20N2O3S	5253	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1499		Sparfloxacin	C19H22F2N4O3	60464	Major		Inter Info	[134], [135], [136]
D1574		Thioridazine	C21H26N2S2	5452	Major		Inter Info	[3], [137], [138]
D1612		Toremifene	C26H28ClNO	3005573	Major		Inter Info	[1], [2], [3], [139]
D1681		Vandetanib	C22H24BrFN4O2	3081361	Major		Inter Info	[1], [2], [3], [140]
D0003		Abarelix	C72H95ClN14O14	16131215	Moderate		Inter Info	[3], [141], [142], [143], [144], [145], [146], [147]
D0037		Alimemazine	C18H22N2S	5574	Moderate		Inter Info	[50]
D0068		Amitriptyline	C20H23N	2160	Moderate		Inter Info	[50]
D0072		Amoxapine	C17H16ClN3O	2170	Moderate		Inter Info	[50]
D0105		Aripiprazole	C23H27Cl2N3O2	60795	Moderate		Inter Info	[2], [3], [185], [186], [187], [188], [189], [190]
D0112		Asenapine	C17H16ClNO	3036780	Moderate		Inter Info	[1], [2], [3], [191], [13]
D0115		Astemizole	C28H31FN4O	2247	Moderate		Inter Info	[50]
D0119		Atomoxetine	C17H21NO	54841	Moderate		Inter Info	[50]
D0139		Azithromycin	C38H72N2O12	447043	Moderate		Inter Info	[50]
D0180		Bicalutamide	C18H14F4N2O4S	2375	Moderate		Inter Info	[3], [141], [142], [143], [144], [145], [146], [147]
D0219		Buprenorphine	C29H41NO4	644073	Moderate		Inter Info	[50]
D0324		Chlorpromazine	C17H19ClN2S	2726	Moderate		Inter Info	[50]
D0336		Cilostazol	C20H27N5O2	2754	Moderate		Inter Info	[50]
D0341		Ciprofloxacin	C17H18FN3O3	2764	Moderate		Inter Info	[50]
D0349		Clarithromycin	C38H69NO13	84029	Moderate		Inter Info	[50]
D0358		Clofazimine	C27H22Cl2N4	2794	Moderate		Inter Info	[195]
D0361		Clomipramine	C19H23ClN2	2801	Moderate		Inter Info	[50]
D0428		Dasatinib	C22H26ClN7O2S	3062316	Moderate		Inter Info	[50]
D0430		Daunorubicin (liposomal)	C27H29NO10	30323	Moderate		Inter Info	[50]
D0437		Degarelix	C82H103ClN18O16	16136245	Moderate		Inter Info	[3], [141], [142], [143], [144], [145], [146], [147]
D0446		Desipramine	C18H22N2	2995	Moderate		Inter Info	[50]
D0526		Doxepin (topical)	C19H21NO	667477	Moderate		Inter Info	[50]
D0529		Doxorubicin (liposomal)	C27H29NO11	31703	Moderate		Inter Info	[50]
D0569		Encorafenib	C22H27ClFN7O4S	50922675	Moderate		Inter Info	[199]
D0584		Epirubicin	C27H29NO11	41867	Moderate		Inter Info	[50]
D0594		Eribulin	C40H59NO11	11354606	Moderate		Inter Info	[1], [2], [3], [200]
D0632		Ezogabine	C16H18FN3O2	121892	Moderate		Inter Info	[50]
D0636		Famotidine	C8H15N7O2S3	5702160	Moderate		Inter Info	[2], [3], [201]
D0664		Flecainide	C17H20F6N2O3	3356	Moderate		Inter Info	[50]
D0678		Fluphenazine	C22H26F3N3OS	3372	Moderate		Inter Info	[50]
D0682		Flutamide	C11H11F3N2O3	3397	Moderate		Inter Info	[3], [141], [142], [143], [144], [145], [146], [147]
D0577		Entrectinib	C31H34F2N6O2	25141092	Moderate		Inter Info	[2], [3], [202]
D0720		Gilteritinib	C29H44N8O3	49803313	Moderate		Inter Info	[203]
D0725		Glasdegib	C21H22N6O	25166913	Moderate		Inter Info	[204]
D1189		Osilodrostat	C13H10FN3	44139752	Moderate		Inter Info	[3], [205]
D1388		Relugolix	C29H27F2N7O5S	10348973	Moderate		Inter Info	[3], [141], [142], [143], [144], [145], [146], [147]
D1432		Rucaparib	C19H18FN3O	9931954	Moderate		Inter Info	[50]
D1634		Triclabendazole	C14H9Cl3N2OS	50248	Moderate		Inter Info	[50]
D0737		Goserelin	C59H84N18O14	5311128	Moderate		Inter Info	[3], [141], [142], [143], [144], [145], [146], [147]
D0751		Halothane	C2HBrClF3	3562	Moderate		Inter Info	[50]
D0758		Histrelin	C66H86N18O12	25077993	Moderate		Inter Info	[3], [141], [142], [143], [144], [145], [146], [147]
D0781		Hydroxyzine	C21H27ClN2O2	3658	Moderate		Inter Info	[50]
D0788		Idarubicin	C26H27NO9	42890	Moderate		Inter Info	[50]
D0795		Imipramine	C19H24N2	3696	Moderate		Inter Info	[50]
D0806		Inotuzumab ozogamicin	NA	NA	Moderate		Inter Info	[3], [209]
D0880		Ketoconazole	C26H28Cl2N4O4	456201	Moderate		Inter Info	[50]
D0894		Lapatinib	C29H26ClFN4O4S	208908	Moderate		Inter Info	[50]
D0903		Lenvatinib	C21H19ClN4O4	9823820	Moderate		Inter Info	[50]
D0919		Levofloxacin	C18H20FN3O4	149096	Moderate		Inter Info	[50]
D0942		Lofexidine	C11H12Cl2N2O	30668	Moderate		Inter Info	[50]
D0943		Lomefloxacin	C17H19F2N3O3	3948	Moderate		Inter Info	[50]
D0947		Loperamide	C29H33ClN2O2	3955	Moderate		Inter Info	[210], [211]
D0979		Maprotiline	C20H23N	4011	Moderate		Inter Info	[50]
D0992		Mefloquine	C17H16F6N2O	4046	Moderate		Inter Info	[50]
D1026		Methotrimeprazine	C19H24N2OS	72287	Moderate		Inter Info	[50]
D1062		Midostaurin	C35H30N4O4	9829523	Moderate		Inter Info	[50]
D1137		Nilutamide	C12H10F3N3O4	4493	Moderate		Inter Info	[3], [141], [142], [143], [144], [145], [146], [147]
D1155		Norfloxacin	C16H18FN3O3	4539	Moderate		Inter Info	[50]
D1158		Nortriptyline	C19H21N	4543	Moderate		Inter Info	[50]
D1165		Ofloxacin	C18H20FN3O4	4583	Moderate		Inter Info	[50]
D1166		Olanzapine	C17H20N4S	135398745	Moderate		Inter Info	[2], [3], [212]
D1181		Ondansetron	C18H19N3O	4595	Moderate		Inter Info	[50]
D1193		Oxaliplatin	C8H14N2O4Pt	9887053	Moderate		Inter Info	[50]
D1210		Oxytocin	C43H66N12O12S2	439302	Moderate		Inter Info	[50]
D1215		Paliperidone	C23H27FN4O3	115237	Moderate		Inter Info	[50]
D1216		Palonosetron	C19H24N2O	6337614	Moderate		Inter Info	[50]
D1246		Pentamidine	C19H24N4O2	4735	Moderate		Inter Info	[50]
D1254		Perflutren	C3F8	6432	Moderate		Inter Info	[213], [214]
D1290		Pimavanserin	C25H34FN3O2	10071196	Moderate		Inter Info	[217]
D1302		Pitolisant	C17H26ClNO	9948102	Moderate		Inter Info	[3], [218]
D1315		Posaconazole	C37H42F2N8O4	468595	Moderate		Inter Info	[50]
D1339		Primaquine	C15H21N3O	4908	Moderate		Inter Info	[50]
D1342		Probucol	C31H48O2S2	4912	Moderate		Inter Info	[50]
D1346		Prochlorperazine	C20H24ClN3S	4917	Moderate		Inter Info	[50]
D1353		Propafenone	C21H27NO3	4932	Moderate		Inter Info	[50]
D1361		Protriptyline	C19H21N	4976	Moderate		Inter Info	[50]
D1368		Quetiapine	C21H25N3O2S	5002	Moderate		Inter Info	[1], [2], [3], [48], [219], [220], [221], [222], [13]
D1372		Quinine	C20H24N2O2	3034034	Moderate		Inter Info	[50]
D1383		Ranolazine	C24H33N3O4	56959	Moderate		Inter Info	[223], [224]
D1404		Rilpivirine	C22H18N6	6451164	Moderate		Inter Info	[50]
D1413		Risperidone	C23H27FN4O2	5073	Moderate		Inter Info	[50]
D1424		Romidepsin	C24H36N4O6S2	5352062	Moderate		Inter Info	[50]
D1461		Sertraline	C17H17Cl2N	68617	Moderate		Inter Info	[50]
D1463		Sevoflurane	C4H3F7O	5206	Moderate		Inter Info	[1], [2], [3], [225]
D1491		Solifenacin	C23H26N2O2	154059	Moderate		Inter Info	[50]
D1497		Sorafenib	C21H16ClF3N4O3	216239	Moderate		Inter Info	[1], [2], [3], [226]
D1522		Sunitinib	C22H27FN4O2	5329102	Moderate		Inter Info	[50]
D1526		Tacrolimus	C44H69NO12	445643	Moderate		Inter Info	[50]
D1533		Tamoxifen	C26H29NO	2733526	Moderate		Inter Info	[50]
D1542		Telavancin	C80H106Cl2N11O27P	3081362	Moderate		Inter Info	[50]
D1544		Telithromycin	C43H65N5O10	3002190	Moderate		Inter Info	[50]
D1555		Terfenadine	C32H41NO2	5405	Moderate		Inter Info	[50]
D1560		Tetrabenazine	C19H27NO3	6018	Moderate		Inter Info	[1], [2], [3], [227], [13]
D1596		Tizanidine	C9H8ClN5S	5487	Moderate		Inter Info	[50]
D1616		Tramadol	C16H25NO2	33741	Moderate		Inter Info	[50]
D1624		Trazodone	C19H22ClN5O	5533	Moderate		Inter Info	[229], [230], [185], [231], [232], [233], [13]
D1637		Trifluoperazine	C21H24F3N3S	5566	Moderate		Inter Info	[50]
D1638		Triflupromazine	C18H19F3N2S	5568	Moderate		Inter Info	[50]
D1647		Trimipramine	C20H26N2	5584	Moderate		Inter Info	[50]
D1651		Triptorelin	C64H82N18O13	25074470	Moderate		Inter Info	[3], [141], [142], [143], [144], [145], [146], [147]
D1682		Vardenafil	C23H32N6O4S	135400189	Moderate		Inter Info	[50]
D1683		Vasopressin	C46H65N15O12S2	644077	Moderate		Inter Info	[50]
D1689		Venlafaxine	C17H27NO2	5656	Moderate		Inter Info	[50]
D1706		Voriconazole	C16H14F3N5O	71616	Moderate		Inter Info	[50]
	Increased risk of ventricular arrhythmias					Drug Num: 30
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0067		Amisulpride	C17H27N3O4S	2159	Major		Inter Info	[14]
D0107		Arsenic trioxide	As2O3	14888	Major		Inter Info	[16], [17]
D0661		Fingolimod	C19H33NO2	107970	Major		Inter Info	[1], [2], [3], [54], [43]
D1211		Ozanimod	C23H24N4O3	52938427	Major		Inter Info	[59]
D1474		Siponimod	C29H35F3N2O3	44599207	Major		Inter Info	[2], [61]
D0868		Ivabradine	C27H36N2O5	132999	Major		Inter Info	[3], [77], [78]
D0025		Adenosine	C10H13N5O4	60961	Moderate		Inter Info	[1], [148], [2], [3], [149], [150], [151], [152], [153], [154]
D0103		Arformoterol	C19H24N2O4	3083544	Moderate		Inter Info	[155], [156], [157], [158], [159], [160], [161], [162], [163], [164], [165], [166], [167], [168], [169], [170], [171], [172], [173], [174], [175], [176], [177], [178], [179], [180], [181], [182], [183], [184]
D0184		Bisacodyl	C22H19NO4	2391	Moderate		Inter Info	[1], [2], [3], [192], [193], [194]
D0269		Castor oil	C57H104O9	14030006	Moderate		Inter Info	[1], [2], [3], [192], [193], [194]
D0516		Donepezil	C24H29NO3	3152	Moderate		Inter Info	[1], [2], [3], [196], [197], [198]
D0701		Frangula purshiana bark	NA	NA	Moderate		Inter Info	[2], [3], [194]
D0887		Lactitol	C12H24O11	157355	Moderate		Inter Info	[1], [2], [3], [192], [193], [194]
D0924		Levosalbutamol	C13H21NO3	123600	Moderate		Inter Info	[168], [178], [181]
D0707		Galantamine	C17H21NO3	9651	Moderate		Inter Info	[1], [2], [3], [196], [197], [198]
D0797		Indacaterol	C24H28N2O3	6918554	Moderate		Inter Info	[155], [156], [157], [158], [159], [160], [161], [162], [163], [164], [165], [166], [167], [168], [169], [170], [171], [172], [173], [174], [175], [176], [177], [178], [179], [180], [181], [182], [183], [184]
D0854		Isoetharine	C13H21NO3	3762	Moderate		Inter Info	[155], [156], [157], [158], [159], [160], [161], [162], [163], [164], [165], [166], [167], [168], [169], [170], [171], [172], [173], [174], [175], [176], [177], [178], [179], [180], [181], [182], [183], [184]
D0888		Lactulose	C12H22O11	11333	Moderate		Inter Info	[1], [2], [3], [192], [193], [194]
D0970		Magnesium citrate	C12H10Mg3O14	6099959	Moderate		Inter Info	[1], [2], [3], [192], [193], [194]
D1171		Olodaterol	C21H26N2O5	11504295	Moderate		Inter Info	[155], [156], [157], [158], [159], [160], [161], [162], [163], [164], [165], [166], [167], [168], [169], [170], [171], [172], [173], [174], [175], [176], [177], [178], [179], [180], [181], [182], [183], [184]
D1185		Orciprenaline	C11H17NO3	4086	Moderate		Inter Info	[168], [178], [181]
D1266		Phenolphthalein	C20H14O4	4764	Moderate		Inter Info	[1], [2], [3], [192], [193], [194]
D1287		Picosulfuric acid	C18H15NO8S2	5243	Moderate		Inter Info	[3], [215], [216]
D1298		Pirbuterol	C12H20N2O3	4845	Moderate		Inter Info	[155], [156], [157], [158], [159], [160], [161], [162], [163], [164], [165], [166], [167], [168], [169], [170], [171], [172], [173], [174], [175], [176], [177], [178], [179], [180], [181], [182], [183], [184]
D1309		Polyethylene glycol (3350)	C2H6O2	174	Moderate		Inter Info	[2], [3], [194]
D1488		Sodium sulfate	Na2O4S	24436	Moderate		Inter Info	[3], [215], [216]
D1525		Tacrine	C13H14N2	1935	Moderate		Inter Info	[1], [2], [3], [196], [197], [198]
D1554		Terbutaline	C12H19NO3	5403	Moderate		Inter Info	[155], [156], [157], [158], [159], [160], [161], [162], [163], [164], [165], [166], [167], [168], [169], [170], [171], [172], [173], [174], [175], [176], [177], [178], [179], [180], [181], [182], [183], [184]
D1569		Thalidomide	C13H10N2O4	5426	Moderate		Inter Info	[2], [3], [228]
D1695		Vilanterol	C24H33Cl2NO5	10184665	Moderate		Inter Info	[168], [178], [181]

References
1	Canadian Pharmacists Association.
2	Cerner Multum, Inc. "Australian Product Information.".
3	Cerner Multum, Inc. "UK Summary of Product Characteristics.".
4	Maxa JL, Hebeler RF, Adeeko MA "Torsades de pointes following concurrent amiodarone and levofloxacin therapy." Proc (Bayl Univ Med Cent) 19 (2006): 345-6. [PMID: 17106497]
5	Product Information. Betapace (sotalol). Berlex, Richmond, CA.
6	Product Information. Cordarone (amiodarone). Wyeth-Ayerst Laboratories, Philadelphia, PA.
7	Product Information. Norpace (disopyramide). Searle, Skokie, IL.
8	Product Information. Procan SR (procainamide). Parke-Davis, Morris Plains, NJ.
9	Product Information. Quiniglute (quinidine). Berlex, Richmond, CA.
10	Product Information. Vascor (bepridil). McNeil Pharmaceutical, Raritan, NJ.
11	Trujillo TC, Nolan PE "Antiarrhythmic agents - Drug interactions of clinical significance." Drug Safety 23 (2000): 509-32. [PMID: 11144659]
12	Yamreudeewong W, DeBisschop M, Martin L, Lower D "Potentially Significant Drug Interactions of Class III Antiarrhythmic Drugs." Drug Saf 26 (2003): 421-38. [PMID: 12688833]
13	EMA. European Medicines Agency. European Union "EMA - List of medicines under additional monitoring.".
14	Product Information. Barhemsys (amisulpride). Acacia Pharma, Inc, Indianapolis, IN.
15	Product Information. Agrylin (anagrelide). Roberts Pharmaceutical Corporation, Eatontown, NJ.
16	Ohnishi K, Yoshida H, Shigeno K, et al. "Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia." Ann Intern Med 133 (2000): 881-5. [PMID: 11103058]
17	Product Information. Trisenox (arsenic trioxide) Cephalon Inc, West Chester, PA.
18	Product Information. Sirturo (bedaquiline). Janssen Pharmaceuticals, Titusville, NJ.
19	Product Information. Cometriq (cabozantinib). Exelixis Inc, S San Francisco, CA.
20	Product Information. Zykadia (ceritinib). Novartis Pharmaceuticals, East Hanover, NJ.
21	Harper KM, Knapp DJ, Criswell HE, Breese GR "Vasopressin and alcohol: A multifaceted relationship." Psychopharmacology (Berl) 235 (2018): 3363-79. [PMID: 32936259]
22	Javelot H, El-Hage W, Meyer G, Becker G, Michel B, Hingray C "COVID-19 and (hydroxy)chloroquine-azithromycin combination: should we take the risk for our patients?" Br J Clin Pharmacol Apr 29 (2020): epub ahead of print. [PMID: 32350872]
23	National Institutes of Health (NIH) "Coronavirus Disease 2019 (COVID-19) Treatment Guidelines.".
24	Product Information. Chloroquine Phosphate (chloroquine). West-Ward Pharmaceutical Corporation, Eatontown, NJ.
25	Product Information. Hydroxychloroquine Sulfate (hydroxychloroquine). Prasco Laboratories, Cincinnati, OH.
26	Product Information. Plaquenil (R). (hydroxychloroquine). Sanofi Winthrop Pharmaceuticals, New York, NY.
27	Roden DM, Harrington RA, Poppas A, Russo AM "Considerations for drug interactions on QTc in exploratory COVID-19 (Coroanvirus disease 2019) treatment." Heart Rhythm Apr 14 (2020): epub ahead of print. [PMID: 32302703]
28	Sacher F, Fauchier L, Boveda S, et.al "Use of drugs with potential cardiac effect in the setting of SARS-CoV-2 infection." Arch Cardiovasc Dis Apr 24 (2020): epub ahead of print. [PMID: 32354666]
29	Saleh M, Gabriels J, ChangD, et.al "The effect of chloroquine, hydroxychloroquine and azithromycin on the corrected QT interval in patients with SARS-CoV-2 infection." Circ Arrhythm Electrophysiol Apr 29 (2020): epub ahead of print. [PMID: 32347743]
30	Sapp JL, Alqarawi W, MacIntyre CJ, et.al "Guidance on minimizing risk of drug-induced ventricular arrhythmia during treatment of COVID-19: A statement from the Canadian Heart Rhythm Society." Can J Cardiol Apr 8 (2020): epub ahead of print. [PMID: 32299753]
31	Smit C, Peeters MYM, van den Anker JN, Knibbe CAJ "Chloroquine for SARS-CoV-2: Implications of its unique pharmacokinetic and safety properties." Clin Pharmacokinet Ar 18 (2020): epub ahead of print. [PMID: 32306288]
32	Bessiere F, Roccia H, Deliniere A, et.al "Assessment of QT intervals in a case series of patients with coronavirus disease 2019 (COVID-19) infection treated with hydroxychloroquine alone or in combination with azithromycin in an intensive care unit." JAMA Cardiol May 1 (2020): epub ahead of print. [PMID: 32936266]
33	Borba MGS, Val FFA, Sampaio VS, et.al "Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 1 (SARS-CoV-2) infection: A randomized clinical trial." JAMA Netw Open Apr 1 (2020): epub ahead of print. [PMID: 32330277]
34	Giudicessi JR, Noseworthy PA, Friedman PA, Ackerman MJ "Urgent guidance for navigating and circumventing the QTc-prolonging and torsadogenic potential of possible pharmacotherapies for coronavirus disease 19 (COVID-19)" Mayo Clin Proc Apr 7 (2020): epub ahead of print. [PMID: 32359771]
35	Kapoor A, Pandurangi U, Arora V, et.al "Cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of COVID-19 patients: A scientific statement from the Indian Heart Rhythm Society." Indian Pacing Electorphysiol J Apr 8 (2020): epub ahead of print. [PMID: 32278018]
36	Mercuro NJ, Yen CF, Shim DJ, et.al "Risk of QT interval prolongation associated with the use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019 (COVID-19)" JAMA Cardiol May 1:e201834 (2020): epub ahead of print. [PMID: 32936252]
37	mitra RL, Greenstein SA, Epstein lm "An algorithm for managing QT prolongation in coronavirus disease 2019 (COVID-19) patients treated with either chloroquine or hydroxychloroquine in conjunction with azithromycin Possible benefits of intravenous lidocaine." HeartRythm Case Rep Apr 1 (2020): epub ahead of print. [PMID: 32363145]
38	US Food and Drug Administration "FACT SHEET FOR HEALTH CARE PROVIDERS EMERGENCY USE AUTHORIZATION (EUA) OF CHLOROQUINE PHOSPHATE SUPPLIED FROM THE STRATEGIC NATIONAL STOCKPILE FOR TREATMENT OF COVID-19 IN CERTAIN HOSPITALIZED PATIENTS. Available from: URL: https://www.fda.gov/media/13653" ([2020, Apr 27]):.
39	US Food and Drug Administration "Hydroxychloroquine or Chloroquine for COVID-19: Drug Safety Communication - FDA Cautions Against Use Outside of the Hospital Setting or a Clinical Trial Due to Risk of Heart Rhythm Problems.".
40	Product Information. Propulsid (cisapride). Janssen Pharmaceutica, Titusville, NJ.
41	FDA. U.S. Food and Drug Administration "FDA Drug Safety Communication: Abnormal heart rhythms associated with high doses of Celexa (citalopram hydrobromide).".
42	Product Information. Celexa (citalopram). Forest Pharmaceuticals, St. Louis, MO.
43	FDA. U.S. Food and Drug Administration "FDA Drug Safety Communication: Revised recommendations for cardiovascular monitoring and use of multiple sclerosis drug Gilenya (fingolimod).".
44	Product Information. Xalkori (crizotinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
45	Product Information. Tikosyn (dofetilide) Pfizer US Pharmaceuticals, Atlanta, GA.
46	Product Information. Anzemet (dolasetron). Hoechst Marion-Roussel Inc, Kansas City, MO.
47	Product Information. Multaq (dronedarone). sanofi-aventis , Bridgewater, NJ.
48	Glassman AH, Bigger JT Jr "Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death." Am J Psychiatry 158 (2001): 1774-82. [PMID: 11691681]
49	Product Information. Inapsine (droperidol). Janssen Pharmaceutica, Titusville, NJ.
50	Product Information. Rukobia (fostemsavir). ViiV Healthcare, Research Triangle Park, NC.
51	Castro VM, Clements CC, Murphy SN, et al. "QT interval and antidepressant use: a cross sectional study of electronic health records." BMJ 346 (2013): f288. [PMID: 23360890]
52	Do A, Noohi S, Elie D, et al. Health Canada Warning on Citalopram and Escitalopram--Its Effects on Prescribing in Consultation-Liaison Psychiatry.?Psychosomatics. 2016;57(1):57-63. [PMID: 26633294]
53	Product Information. Lexapro (escitalopram). Forest Pharmaceuticals, St. Louis, MO.
54	Product Information. Gilenya (fingolimod). Novartis Pharmaceuticals, East Hanover, NJ.
55	Product Information. Fycompa (perampanel). Eisai Inc, Teaneck, NJ.
56	Product Information. Tibsovo (ivosidenib). Agios Pharmaceuticals, Cambridge, MA.
57	Product Information. Xenleta (lefamulin). Nabriva Therapeutics US, Inc., King of Prussia, PA.
58	Warrington SJ, Ankier SI, Turner P "Evaluation of possible interactions between ethanol and trazodone or amitriptyline." Neuropsychobiology 15 (1986): 31-7. [PMID: 3725002]
59	Product Information. Zeposia (ozanimod). Celgene Corporation, Summit, NJ.
60	Product Information. Retevmo (selpercatinib). Lilly, Eli and Company, Indianapolis, IN.
61	Product Information. Mayzent (siponimod). Novartis Pharmaceuticals, East Hanover, NJ.
62	Ansari SR, Chopra N "Gatifloxacin and Prolonged QT Interval." Am J Med Sci 327 (2004): 55-6. [PMID: 14722399]
63	Siepmann M, Kirch W "Drug points - Tachycardia associated with moxifloxacin." Br Med J 322 (2001): 23. [PMID: 11141146]
64	Product Information. Nexlizet (bempedoic acid-ezetimibe). Esperion Therapeutics, Ann Arbor, MI.
65	Product Information. Zepatier (elbasvir-grazoprevir). Merck &amp Company Inc, Whitehouse Station, NJ.
66	Product Information. Raxar (grepafloxacin). Glaxo Wellcome, Research Triangle Park, NC.
67	Product Information. Halfan (halofantrine). GlaxoSmithKline, Philadelphia, PA.
68	Product Information. Lariam (mefloquine). Roche Laboratories, Nutley, NJ.
69	Hatta K, Takahashi T, Nakamura H, Yamashiro H, Asukai N, Matsuzaki I, Yonezawa Y "The association between intravenous haloperidol and prolonged QT interval." J Clin Psychopharmacol 21 (2001): 257-61. [PMID: 11386487]
70	Huyse F, van Schijndel RS "Haloperidol and cardiac arrest." Lancet 2 (1988): 568-9. [PMID: 2900948]
71	Metzger E, Friedman R "Prolongation of the corrected QT and torsades de pointes cardiac arrhythmia associated with intravenous haloperidol in the medically ill." J Clin Psychopharmacol 13 (1993): 128-32. [PMID: 8463445]
72	O'Brien JM, Rockwood RP, Suh KI "Haloperidol-induced torsade de pointes." Ann Pharmacother 33 (1999): 1046-9. [PMID: 10534216]
73	Product Information. Haldol (haloperidol). McNeil Pharmaceutical, Raritan, NJ.
74	Wilt JL, Minnema AM, Johnson RF, Rosenblum AM "Torsade de pointes associated with the use of intravenous haloperidol." Ann Intern Med 119 (1993): 391-4. [PMID: 8338292]
75	Product Information. Corvert (ibutilide). Pharmacia and Upjohn, Kalamazoo, MI.
76	Product Information. Exforge HCT (amlodipine/hydrochlorothiazide/valsartan). Novartis Pharmaceuticals, East Hanover, NJ.
77	Mittal SR "Slow junctional rhythm, QTc prolongation and transient torsades de-pointes following combined use of Ivabradine, Diltiazem and Ranolazine." J Assoc Physicians India 62 (2014): 426-7. [PMID: 25438492]
78	Product Information. Corlanor (ivabradine). Amgen USA, Thousand Oaks, CA.
79	Product Information. Orlaam (levomethadyl acetate) Roxanne Laboratories Inc, Columbus, OH.
80	Patel S, Robinson R, Burk M "Hypertensive crisis associated with St. John's Wort." Am J Med 112 (2002): 507-8. [PMID: 11959071]
81	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
82	Product Information. Serentil (mesoridazine) Boehringer-Ingelheim, Ridgefield, CT.
83	De Bels D, Staroukine M, Devriendt J "Torsades de pointes due to methadone." Ann Intern Med 139 (2003): E156. [PMID: 12859181]
84	Ehret GB, Desmeules JA, Broers B "Methadone-associated long QT syndrome: improving pharmacotherapy for dependence on illegal opioids and lessons learned for pharmacology." Expert Opin Drug Saf 6 (2007): 289-303. [PMID: 17480178]
85	Gil M, Sala M, Anguera I, et al. "QT prolongation and Torsades de Pointes in patients infected with human immunodeficiency virus and treated with methadone." Am J Cardiol 92 (2003): 995-7. [PMID: 14556883]
86	Krantz MJ, Kutinsky IB, Robertson AD, Mehler PS "Dose-related effects of methadone on QT prolongation in a series of patients with torsade de pointes." Pharmacotherapy 23 (2003): 802-5. [PMID: 12820821]
87	Krantz MJ, Lewkowiez L, Hays H, et al "Torsade de pointes associated with very-high-dose methadone." Ann Intern Med 137 (2002): 501-4. [PMID: 12230351]
88	Krantz MJ, Mehler PS "Synthetic opioids and QT prolongation." Arch Intern Med 163 (2003): 1615 author reply 1615. [PMID: 12860589]
89	Martell BA, Arnsten JH, Krantz MJ, Gourevitch MN "Impact of methadone treatment on cardiac repolarization and conduction in opioid users." Am J Cardiol 95 (2005): 915-8. [PMID: 15781034]
90	Mokwe EO, Ositadinma O "Torsade de pointes due to methadone." Ann Intern Med 139 (2003): W64. [PMID: 12966000]
91	Sala M, Anguera I, Cervantes M "Torsade de pointes due to methadone." Ann Intern Med 139 (2003): W64. [PMID: 12966001]
92	Walker PW, Klein D, Kasza L "High dose methadone and ventricular arrhythmias: a report of three cases." Pain 103 (2003): 321-4. [PMID: 12791438]
93	Product Information. Korlym (mifepristone). Corcept Therapeutics Incorporated, Menlo Park, CA.
94	Ball P "Quinolone-induced QT interval prolongation: a not-so-unexpected class effect." J Antimicrob Chemother 45 (2000): 557-9. [PMID: 10797074]
95	Bertino JS Jr, Owens RC Jr, Carnes TD, Iannini PB "Gatifloxacin-associated corrected QT interval prolongation, torsades de pointes, and ventricular fibrillation in patients with known risk factors." Clin Infect Dis 34 (2002): 861-3. [PMID: 11830802]
96	Dale KM, Lertsburapa K, Kluger J, White CM "Moxifloxacin and torsade de pointes." Ann Pharmacother 41 (2007): 336-40. [PMID: 17284508]
97	Demolis JL, Kubitza D, Tenneze L, Funck-Bretano C "Effect of a single oral dose of moxifloxacin (400 mg and 800 mg) on ventricular repolarization in healthy subjects." Clin Pharmacol Ther 68 (2000): 658-66. [PMID: 11180026]
98	Falagas ME, Rafailidis PI, Rosmarakis ES "Arrhythmias associated with fluoroquinolone therapy." Int J Antimicrob Agents 29 (2007): 374-9. [PMID: 17241772]
99	Frothingham R "Rates of torsades de pointes associated with ciprofloxacin, ofloxacin, levofloxacin, gatifloxacin, and moxifloxacin." Pharmacotherapy 21 (2001): 1468-72. [PMID: 11765299]
100	Iannini PB "Cardiotoxicity of macrolides, ketolides and fluoroquinolones that prolong the QTc interval." Expert Opin Drug Saf 1 (2002): 121-8. [PMID: 12904146]
101	Iannini PB, Circiumaru I "Gatifloxacin-induced QTc prolongation and ventricular tachycardia." Pharmacotherapy 21 (2001): 361-2. [PMID: 11253862]
102	Iannini PB, Doddamani S, Byazrova E, Curciumaru I, Kramer H "Risk of torsades de pointes with non-cardiac drugs." BMJ 322 (2001): 46-7. [PMID: 11141163]
103	Kang J, Wang L, Chen XL, Triggle DJ, Rampe D "Interactions of a series of fluoroquinolone antibacterial drugs with the human cardiac K+ channel HERG." Mol Pharmacol 59 (2001): 122-6. [PMID: 11125032]
104	Katritsis D, Camm AJ "Quinolones: cardioprotective or cardiotoxic." Pacing Clin Electrophysiol 26 (2003): 2317-20. [PMID: 14675020]
105	Noel GJ, Natarajan J, Chien S, Hunt TL, Goodman DB, Abels R "Effects of three fluoroquinolones on QT interval in healthy adults after single doses." Clin Pharmacol Ther 73 (2003): 292-303. [PMID: 12709719]
106	Oliphant CM, Green GM "Quinolones: a comprehensive review." Am Fam Physician 65 (2002): 455-64. [PMID: 11858629]
107	Owens RC "QT Prolongation with Antimicrobial Agents : Understanding the Significance." Drugs 64 (2004): 1091-124. [PMID: 15139788]
108	Owens RC "Risk assessment for antimicrobial agent-induced QTc interval prolongation and torsades de pointes." Pharmacotherapy 21 (2001): 301-19. [PMID: 11253855]
109	Owens RC Jr, Ambrose PG "Torsades de pointes associated with fluoroquinolones." Pharmacotherapy 22 (2002): 663-8 discussion 668-72. [PMID: 12013370]
110	Product Information. Avelox (moxifloxacin) Bayer, West Haven, CT.
111	Product Information. Tequin (gatifloxacin) Bristol-Myers Squibb, Princeton, NJ.
112	Stahlmann R "Clinical toxicological aspects of fluoroquinolones." Toxicol Lett 127 (2002): 269-77. [PMID: 12052667]
113	Tsikouris JP, Peeters MJ, Cox CD, Meyerrose GE, Seifert CF "Effects of three fluoroquinolones on QT analysis after standard treatment courses." Ann Noninvasive Electrocardiol 11 (2006): 52-6. [PMID: 16472283]
114	White CM, Grant EM, Quintiliani R "Moxifloxacin does increase the corrected QT interval." Clin Infect Dis 33 (2001): 1441-2. [PMID: 11565091]
115	Product Information. Tasigna (nilotinib). Novartis Pharmaceuticals, East Hanover, NJ.
116	Product Information. Tagrisso (osimertinib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
117	Product Information. Farydak (panobinostat). Novartis Pharmaceuticals, East Hanover, NJ.
118	Goto M, Sato M, Kitzazawa H, et.al "Papaverine-induced QT interval prolongation and ventricular fibrillation in a patient with a history of drug-induced QT prolongation." Intern Med 53 (2014): 1629-31. [PMID: 25088875]
119	Inoue T, Asahi S, Takayanagi K, Morooka S, Takabatake Y "QT prolongation and possibility of ventricular arrhythmias after intracoronary papaverine." Cardiology 84 (1994): 9-13. [PMID: 7511988]
120	Jain A, Jenkins MG "Intracoronary electrocardiogram during torsade des pointes secondary to intracoronary papaverine." Cathet Cardiovasc Diagn 18 (1989): 255-7. [PMID: 2605630]
121	Kern MJ, Deligonul U, Serota H, Gudipati C, Buckingham T "Ventricular arrhythmia due to intracoronary papaverine: analysis of QT intervals and coronary vasodilatory reserve." Cathet Cardiovasc Diagn 19 (1990): 229-36. [PMID: 2334953]
122	Nakayama M, Saito A, Kitazawa H, et.al "Papaverine-induced polymorphic ventricular tachycardia in relation to QTU and giant T-U waves in four cases." Intern Med 51 (2012): 351-6. [PMID: 22333368]
123	Nakayama M, Tanaka N, Sakoda K, et.al "Papaverine-induced polymorphic ventricular tachycardia during coronary flow reserve study of patients with moderate coronary artery disease." Circ J 79 (2015): 530-6. [PMID: 25746536]
124	Talman CL, Winniford MD, Rossen JD, Simonetti I, Kienzle MG, Marcus ML "Polymorphous ventricular tachycardia: a side effect of intracoronary papaverine." J Am Coll Cardiol 15 (1990): 275-8. [PMID: 2299067]
125	Vrolix M, Piessens J, De Geest H "Torsades de pointes after intracoronary papaverine." Eur Heart J 12 (1991): 273-6. [PMID: 2044564]
126	Product Information. Signifor (pasireotide). Novartis Pharmaceuticals, East Hanover, NJ.
127	Product Information. Orap Tablets (pimozide). Gate Pharmaceuticals, Sellersville, PA.
128	Product Information. Kisqali (ribociclib). Novartis Pharmaceuticals, East Hanover, NJ.
129	Witchel HJ, Hancox JC, Nutt DJ "Psychotropic drugs, cardiac arrhythmia, and sudden death." J Clin Psychopharmacol 23 (2003): 58-77. [PMID: 12544377]
130	Anson BD, Weaver JG, Ackerman MJ, et al. "Blockade of HERG channels by HIV protease inhibitors." Lancet 365 (2005): 682-686. [PMID: 15721475]
131	Biondi L "Health Canada endorsed important safety information on Invirase (saquinavir mesylate)." .
132	Product Information. Invirase (saquinavir). Roche Laboratories, Nutley, NJ.
133	FDA. U.S. Food and Drug Administration "FDA drug safety communication: Ongoing safety review of Invirase (saquinavir) and possible association with abnormal heart rhythms.".
134	Dupont H, Timsit JF, Souweine B, Gachot B, Wolff M, Regnier B "Torsades de pointe probably related to sparfloxacin." Eur J Clin Microbiol Infect Dis 15 (1996): 350-1. [PMID: 8781892]
135	Jaillon P, Morganroth J, Brumpt I, Talbot G "Overview of electrocardiographic and cardiovascular safety data for sparfloxacin. Sparfloxacin Safety Group." J Antimicrob Chemother 37(suppl a) (1996): 161-7. [PMID: 8737135]
136	Thomas M, Maconochie JG, Fletcher E "The dilemma of the prolonged QT interval in early drug studies." Br J Clin Pharmacol 41 (1996): 77-81. [PMID: 8838432]
137	Liberatore MA, Robinson DS "Torsade de pointes: a mechanism for sudden death associated with neuroleptic drug therapy?" J Clin Psychopharmacol 4 (1984): 143-6. [PMID: 6145728]
138	Product Information. Mellaril (thioridazine). Sandoz Pharmaceuticals Corporation, East Hanover, NJ.
139	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
140	Product Information. Vandetanib (vandetanib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
141	Product Information. Eligard (leuprolide). Sanofi Winthrop Pharmaceuticals, New York, NY.
142	Product Information. Firmagon (degarelix). Ferring Pharmaceuticals Inc, Tarrytown, NY.
143	Product Information. Lupron (leuprolide). TAP Pharmaceuticals Inc, Deerfield, IL.
144	Product Information. Plenaxis (abarelix). Praecis Pharmaceuticals Inc, Waltham, MA.
145	Product Information. Trelstar (triptorelin) Pharmacia and Upjohn, Kalamazoo, MI.
146	Product Information. Vantas (histrelin). Endo Pharmaceuticals (formally Indevus Pharmaceuticals Inc), Lexington, MA.
147	Product Information. Zoladex (goserelin). Zeneca Pharmaceuticals, Wilmington, DE.
148	Celiker A, Tokel K, Cil E, Ozkutlu S, Ozme S "Adenosine induced torsades de pointes in a child with congenital long QT syndrome." Pacing Clin Electrophysiol 17 (1994): 1814-7. [PMID: 7838793]
149	Teodorovich N, Margolin E, Kogan Y, Paz O, Swissa M. Torsades de pointes after adenosine administration. J Electrocardiol. 2016;49(2):171-173. [PMID: 26850499]
150	Harrington GR, Froelich EG "Adenosine-induced torsades de pointes." Chest 103 (1993): 1299-1301. [PMID: 8131497]
151	Mallet ML "Proarrhythmic effects of adenosine: a review of the literature." Emerg Med J 21 (2004): 408-10. [PMID: 15208219]
152	Michalets EL, Williams CR "Drug interactions with cisapride: clinical implications." Clin Pharmacokinet 39 (2000): 49-75. [PMID: 10926350]
153	Tachakra SS, Robinson S "Adenosine and cardiac arrhythmias." BMJ 305 (1992): 422. [PMID: 1392935]
154	Wesley RC Jr, Turnquest P "Torsades de pointe after intravenous adenosine in the presence of prolonged QT syndrome." Am Heart J 123 (1992): 794-6. [PMID: 1539535]
155	Bengtsson B, Fagerstrom PO "Extrapulmonary effects of terbutaline during prolonged administration." Clin Pharmacol Ther 31 (1982): 726-32. [PMID: 7042176]
156	Braden GL, vonOeyen PT, Germain MJ, Watson DJ, Haag BL "Ritodrine- and terbutaline-induced hypokalemia in preterm labor: Mechanisms and consequences." Kidney Int 51 (1997): 1867-75. [PMID: 9186877]
157	Clifton GD, Hunt BA, Patel RC, Burki NK "Effects of sequential doses of parenteral terbutaline on plasma levels of potassium and related cardiopulmonary responses." Am Rev Respir Dis 141 (1990): 575-9. [PMID: 2178522]
158	Dickens GR, Mccoy RA, West R, Stapczynski JS, Clifton GD "Effect of nebulized albuterol on serum potassium and cardiac rhythm in patients with asthma or chronic obstructive pulmonary disease." Pharmacotherapy 14 (1994): 729-33. [PMID: 7885977]
159	Ferguson GT, Funck-Brentano C, Fischer T, Darken P, Reisner C "Cardiovascular Safety of Salmeterol in COPD." Chest 123 (2003): 1817-24. [PMID: 12796155]
160	Gelmont DM, Balmes JR, Yee A "Hypokalemia induced by inhaled bronchodilators." Chest 94 (1988): 763-6. [PMID: 3168573]
161	Gross TL, Sokol RJ "Severe hypokalemia and acidosis: a potential complication of beta- adrenergic treatment." Am J Obstet Gynecol 138 (1980): 1225-6. [PMID: 7446635]
162	Hastwell G, Lambert BE "The effect of oral salbutamol on serum potassium and blood sugar." Br J Obstet Gynaecol 85 (1978): 767-9. [PMID: 708661]
163	Hurlbert BJ, Edelman JD, David K "Serum potassium levels during and after terbutaline." Anesth Analg 60 (1981): 723-5. [PMID: 7197475]
164	Hypokalaemia due to salbutamol overdosage. Br Med J (Clin Res Ed) 283 (1981): 500-1. [PMID: 6114774]
165	Kantola I, Tarssanen L "Hypokalemia from usual salbutamol dosage ." Chest 89 (1986): 619-20. [PMID: 3956296]
166	Lowe MD, Rowland E, Brown MJ, Grace AA "Beta(2) adrenergic receptors mediate important electrophysiological effects in human ventricular myocardium." Heart 86 (2001): 45-51. [PMID: 11410561]
167	Milic M, Bao X, Rizos D, Liu F, Ziegler MG "Literature review and pilot studies of the effect of qt correction formulas on reported beta(2)-agonist-induced QTc prolongation." Clin Ther 28 (2006): 582-90. [PMID: 16750469]
168	Product Information. Arcapta Neohaler (indacaterol). Novartis Pharmaceuticals, East Hanover, NJ.
169	Product Information. Breo Ellipta (fluticasone-vilanterol). GlaxoSmithKline, Research Triangle Park, NC.
170	Product Information. Brovana (arformoterol). Sepracor Inc, Marlborough, MA.
171	Product Information. Foradil (formoterol) Novartis Pharmaceuticals, East Hanover, NJ.
172	Product Information. Maxair (pirbuterol). 3M Pharmaceuticals, St. Paul, MN.
173	Product Information. Proventil (albuterol). Schering Laboratories, Kenilworth, NJ.
174	Product Information. Severent (salmeterol). Glaxo Wellcome, Research Triangle Park, NC.
175	Product Information. Striverdi Respimat (olodaterol). Boehringer Ingelheim, Ridgefield, CT.
176	Product Information. Xopenex (levalbuterol). Sepracor, Marlborough, MA.
177	Rakhmanina NY, Kearns GL, Farrar HC "Hypokalemia in an asthmatic child from abuse of albuterol metered dose inhaler." Pediatr Emerg Care 14 (1998): 145-7. [PMID: 9583400]
178	Sanders JP, Potter DE, Ellis S, Bee DE, Grant JA "Metabolic and cardiovascular effects of carbuterol and metaproterenol." J Allergy Clin Immunol 60 (1977): 174-9. [PMID: 19514]
179	Sun ZH, Swan H, Vitasalo M, Toivonen L "Effects of epinephrine and phenylephrine on QT interval dispersion in congenital long QT syndrome." J Am Coll Cardiol 31 (1998): 1400-5. [PMID: 9581741]
180	Tveskov C, Djurhuus MS, Klitgaard NAH, Egstrup K "Potassium and magnesium distribution, ECG changes, and ventricular ectopic beats during beta(2)-adrenergic stimulation with terbutaline in healthy subjects." Chest 106 (1994): 1654-9. [PMID: 7988180]
181	Whyte KF, Addis GJ, Whitesmith R, Reid JL "The mechanism of salbutamol-induced hypokalaemia." Br J Clin Pharmacol 23 (1987): 65-71. [PMID: 3545273]
182	Windom H, Grainger J, Burgess C, Crane J, Pearce N, Beasley R "A comparison of the haemodynamic and hypokalaemic effects of inhaled pirbuterol and salbutamol." N Z Med J 103 (1990): 259-61. [PMID: 1972557]
183	Wong CS, Pavord ID, Williams J, Britton JR, Tattersfield AE "Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma." Lancet 336 (1990): 1396-9. [PMID: 1978872]
184	Larsson S, Svedmyr N "Bronchodilating effect and side effects of beta2- adrenoceptor stimulants by different modes of administration (tablets, metered aerosol, and combinations thereof). A study with salbutamol inasthmatics." Am Rev Respir Dis 116 (1977): 861-9. [PMID: 921062]
185	Goodnick PJ, Jerry J, Parra F "Psychotropic drugs and the ECG: focus on the QTc interval." Expert Opin Pharmacother 3 (2002): 479-98. [PMID: 11996627]
186	Kane JM, Carson WH, Saha AR, et al. "Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder." J Clin Psychiatry 63 (2002): 763-71. [PMID: 12363115]
187	Keck PE Jr, Marcus R, Tourkodimitris S, et al. "A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania." Am J Psychiatry 160 (2003): 1651-8. [PMID: 12944341]
188	Nelson S, Leung JG "Torsades de Pointes After Administration of Low-Dose Aripiprazole (February)." Ann Pharmacother (2013):. [PMID: 23362038]
189	Pigott TA, Carson WH, Saha AR, Torbeyns AF, Stock EG, Ingenito GG "Aripiprazole for the prevention of relapse in stabilized patients with chronic schizophrenia: a placebo-controlled 26-week study." J Clin Psychiatry 64 (2003): 1048-56. [PMID: 14628980]
190	Product Information. Abilify (aripiprazole). Bristol-Myers Squibb, Princeton, NJ.
191	Product Information. Saphris (asenapine). Schering-Plough Corporation, Kenilworth, NJ.
192	Chin RL "Laxative-induced hypokalemia." Ann Emerg Med 32 (1998): 517-8. [PMID: 9774942]
193	Muller-Lissner SA "Adverse effects of laxatives: fact and fiction." Pharmacology 47 (1993): 138-45. [PMID: 8234421]
194	Schaefer DC, Cheskin LJ "Constipation in the elderly." Am Fam Physician 58 (1998): 907-14. [PMID: 9767726]
195	Product Information. Lamprene (clofazimine). Novartis Pharmaceuticals, East Hanover, NJ.
196	Product Information. Aricept (donepezil). Pfizer US Pharmaceuticals, New York, NY.
197	Product Information. Exelon (rivastigmine) Novartis Pharmaceuticals, East Hanover, NJ.
198	Product Information. Razadyne (galantamine). Johnson and Johnson Medical Inc, Arlington, TX.
199	Product Information. Braftovi (encorafenib). Array BioPharma Inc., Boulder, CO.
200	Product Information. Halaven (eribulin). Eisai Inc, Teaneck, NJ.
201	Product Information. Pepcid (famotidine). Merck & Co, Inc, West Point, PA.
202	Product Information. Rozlytrek (entrectinib). Genentech, South San Francisco, CA.
203	Product Information. Xospata (gilteritinib). Astellas Pharma US, Inc, Deerfield, IL.
204	Product Information. Daurismo (glasdegib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
205	Product Information. Isturisa (osilodrostat). Recordati Rare Diseases Inc, Lebanon, NJ.
206	Product Information. Nexletol (bempedoic acid). Esperion Therapeutics, Ann Arbor, MI.
207	Product Information. Yupelri (revefenacin). Mylan Specialty, Morgantown, WV.
208	Product Information. Nurtec ODT (rimegepant). Biohaven Pharmaceuticals, New Haven, CT.
209	Product Information. Besponsa (inotuzumab ozogamicin). Wyeth Laboratories, Philadelphia, PA.
210	Eggleston W, Clark KH, Marraffa JM "Loperamide abuse associated with cardiac dysrhythmia and death." Ann Emerg Med 69 (2017): 83-6. [PMID: 27140747]
211	US Food and Drug Administration "FDA warns about serious heart problems with high doses of the antidiarrheal medicine loperamide (Imodium), including from abuse and misuse.".
212	Product Information. Zyprexa (olanzapine). Lilly, Eli and Company, Indianapolis, IN.
213	Product Information. Definity (perflutren). Lantheus Medical Imaging Inc, North Billerica, MA.
214	Product Information. Optison (perflutren). Mallinckrodt Medical Inc, St. Louis, MO.
215	Product Information. Suclear (polyethylene glycol 3350 with electrolytes). Braintree Laboratories, Braintree, MA.
216	Product Information. Suprep Bowel Prep Kit (magnesium/potassium/sodium sulfates). Braintree Laboratories, Braintree, MA.
217	Product Information. Nuplazid (pimavanserin). Accelis Pharma, East Windsor, NJ.
218	Product Information. Wakix (pitolisant). Harmony Biosciences, LLC, Plymouth Meeting, PA.
219	Product Information. Seroquel (quetiapine). Zeneca Pharmaceuticals, Wilmington, DE.
220	Sala M, Vicentini A, Brambilla P, et al. "QT interval prolongation related to psychoactive drug treatment: a comparison of monotherapy versus polytherapy." Ann Gen Psychiatry 4 (2005): 1. [PMID: 15845138]
221	Vieweg WV "New generation antipsychotic drugs and QTc interval prolongation." Prim Care Companion J Clin Psychiatry 5 (2003): 205-15. [PMID: 15213787]
222	Vieweg WV, Schneider RK, Wood MA "Torsade de pointes in a patient with complex medical and psychiatric conditions receiving low-dose quetiapine." Acta Psychiatr Scand 112 (2005): 318-22. [PMID: 16156840]
223	European Medicines Agency "CHMP Assessment Report for Latixa. International nonproprietary name: ranolazine.".
224	Product Information. Ranexa (ranolazine). Calmoseptine Inc, Huntington Beach, CA.
225	Product Information. Ultane (sevoflurane). Abbott Pharmaceutical, Abbott Park, IL.
226	Product Information. Nexavar (sorafenib). Bayer Pharmaceutical Inc, West Haven, CT.
227	Product Information. Xenazine (tetrabenazine). Prestwick Pharmaceuticals Inc, Washington DC, VA.
228	Product Information. Thalomid (thalidomide). Celgene Corporation, Warren, NJ.
229	Antonelli D, Atar S, Freedberg NA, Rosenfeld T "Torsade de pointes in patients on chronic amiodarone treatment: contributing factors and drug interactions." Isr Med Assoc J 7 (2005): 163-5. [PMID: 15792261]
230	Dattilo PB, Nordin C "Prolonged QT associated with an overdose of trazodone." J Clin Psychiatry 68 (2007): 1309-10. [PMID: 17854263]
231	Levenson JL "Prolonged QT interval after trazodone overdose." Am J Psychiatry 156 (1999): 969-70. [PMID: 10360146]
232	Mazur A, Strasberg B, Kusniec J, Sclarovsky S "QT prolongation and polymorphous ventricular tachycardia associated with trasodone-amiodarone combination." Int J Cardiol 52 (1995): 27-9. [PMID: 8707432]
233	Product Information. Oleptro (traZODone). Labopharm Inc, Laval, AL.
234	Product Information. Diabinese (chlorpropamide). Pfizer US Pharmaceuticals, New York, NY.
235	Skillman TG, Feldman JM "The pharmacology of sulfonylureas." Am J Med 70 (1981): 361-72. [PMID: 6781341]

Details of Drug

Details of Drug

Cite MecDDI

About MecDDI

Correspondence